US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

34.42

+0.13980.41%

Volume:3K

Turnover:109.54K

Market Cap:13.77M

PE:- -

High:34.47

Open:34.47

Low:34.15

Close:34.28

52wk High:34.86

52wk Low:25.79

Shares:400.00K

Float Shares:400.00K

Volume Ratio:2.61

T/O Rate:0.80%

Dividend:0.08

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Edwards Lifesciences CVP Emeacla Annette Bruls Sells 2,644 Shares Worth $237,903.12

Edwards Lifesciences Strategy Chief Donald Bobo Plans Retirement by Mid-2027

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

Labcorp to Present at Morgan Stanley Healthcare Conference

Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs

Lobe Sciences Names David Kideckel CFO as Mirza Rahimani Shifts to VP Finance

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

SomnoMed Tightens Insider Trading Rules With New Securities Policy

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens

THOMSON REUTERS

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Slips 4.6%, Underperforms Peers

Biogen CEO Viehbacher to Speak at Morgan Stanley Global Healthcare Conference

ABL Diagnostics Calls Shareholder Vote on Move to Euronext Growth and Name Change

IMMUNEONCO-B Advances Phase II Trial for First-Line Advanced Liver Cancer Therapy With Initial Patient Dosing Completed

CSPC Pharma's High-Activity Amylin Receptor Agonist Gets Green Light for Clinical Trials in China

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BMED/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":34.42,"timestamp":1788465600000,"preClose":34.2802,"halted":0,"volume":3201,"delay":0,"changeRate":0.0040781559034078286,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Pre-Mkt","change":0.1398,"latestTime":"09-04 07:37:31 EDT","open":34.47,"high":34.47,"low":34.15,"amount":109541,"amplitude":0.009335,"askPrice":54.72,"askSize":100,"bidPrice":27.95,"bidSize":50,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788528600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":34.42,"sharesOutstanding":360000,"nav":34.280916,"aum":13712366.4,"dividendRate":0.002362,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.42,"preClose":34.42,"latestTime":"16:18 EDT","volume":7,"amount":241.53,"timestamp":1788466684460,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.609652868720226,"impliedVol":0.2836,"impliedVolPercentile":0.7649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.609652868720226,"shares":400000,"dividePrice":0.0813,"high":34.47,"amplitude":0.009335,"preClose":34.2802,"low":34.15,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":34.42,"committee":-0.333333,"eps":0,"divideRate":0.002362,"volume":3201,"delay":0,"ttmEps":0,"open":34.47,"prevYearClose":30.32,"prevWeekClose":33.8786,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":34.5006,"twentyDayClose":31.3112,"sixtyDayClose":28.6562},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663013044","title":"Edwards Lifesciences CVP Emeacla Annette Bruls Sells 2,644 Shares Worth $237,903.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013044","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013044?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:33","pubTimestamp":1787949220,"startTime":"0","endTime":"0","summary":"Edwards Lifesciences CVP EMEACLA Annette Bruls sells 2,644 shares worth $237,903.12Edwards Lifesciences officer Annette Bruls, CVP, EMEACLA, sold 2,644 common shares on Aug. 28, 2026 at $89.98.Directl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL8xz2jT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Edwards Lifesciences CVP Emeacla Annette Bruls Sells 2,644 Shares Worth $237,903.12","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IE00BFXG0V08.USD","BK4504","BK4588","SG9999001176.SGD","IE00BN0W2V16.EUR","SGXZ57979304.SGD","BK4585","IE00BN0W2W23.USD","SG9999001176.USD","IE00BYQQ9H92.USD","LU0289739699.SGD","LU0823416689.USD","LU0058720904.USD","AGNG","SG9999013999.USD","LU0345774631.USD","EW","BMED","BK4567","IE00BN0W2T93.GBP","IHI","LU0345774391.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013287","title":"Edwards Lifesciences Strategy Chief Donald Bobo Plans Retirement by Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013287","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013287?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:16","pubTimestamp":1787948198,"startTime":"0","endTime":"0","summary":"Edwards Lifesciences strategy chief Donald Bobo plans retirement by mid-2027Edwards Lifesciences received notice that Donald E. Bobo Jr. will retire as corporate vice president, strategy and corporate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLbMyq4w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EW","SG9999001176.SGD","LU0058720904.USD","BK4504","BK4585","LU0289739699.SGD","LU0345774391.USD","BK4588","BMED","SGXZ57979304.SGD","IHI","SG9999013999.USD","LU0823416689.USD","SG9999001176.USD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU0345774631.USD","IE00BFXG0V08.USD","IE00BYQQ9H92.USD","BK4567","BK4082","AGNG","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018885","title":"Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018885","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018885?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:20","pubTimestamp":1787937637,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock was down roughly 2% on Friday alongside an FDA update concerning HIV drug Bixlenvo.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4578","SG9999015978.USD","LU2112291526.USD","IBBQ","TMED","LU0859254822.USD","IE00B19Z3581.USD","LU0320765992.SGD","LABU","LU1674673691.USD","LU0114720955.EUR","LU1934455277.USD","LU2357627491.SGD","BK4566","GILD","MEDI","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU0965509010.AUD","LU1585245621.USD","LU1778281490.HKD","LU0122379950.USD","IE00B19Z3B42.SGD","LU0965509101.SGD","SG9999015986.USD","BK4532","LU0823416689.USD","LU1066051498.USD","IBB","LU1934455863.HKD","LU0109394709.USD","BK4139","LU0889565916.HKD","LU1057294990.SGD","LU1066053197.SGD","BMED","LU1934455194.USD","IE00B3T34201.USD","SG9999015945.SGD","BK4585","IE0002270589.USD","LU1571399168.USD","BBH","BIB","TBXU","LU0882574055.USD","LU1037948897.HKD","BK4588","IE00BSNM7G36.USD","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662009682","title":"Labcorp to Present at Morgan Stanley Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662009682","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662009682?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:36","pubTimestamp":1787924191,"startTime":"0","endTime":"0","summary":"Labcorp Holdings ( ($LH) ) has issued an announcement. Labcorp Holdings Inc., a global leader in diagnostics and drug development laboratory servic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/labcorp-to-present-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/labcorp-to-present-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LABU","BK4585","HCSG","BK4581","LFSC","XLV","BK4588","FBT","LU0029874061.USD","BK4137","XBI","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098595","title":"Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098595","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098595?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:15","pubTimestamp":1787919300,"startTime":"0","endTime":"0","summary":"Company Strengthens Global Intellectual Property Portfolio with 28 Issued and 30 Pending PatentsDOYLESTOWN, Pa., Aug.  28, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/28/3352669/0/en/aprea-therapeutics-announces-expansion-of-intellectual-property-portfolio-for-precision-oncology-programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","GDOC","BK4007","IDNA","BMED","BK4539","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662609980","title":"Lobe Sciences Names David Kideckel CFO as Mirza Rahimani Shifts to VP Finance","url":"https://stock-news.laohu8.com/highlight/detail?id=2662609980","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662609980?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:00","pubTimestamp":1787918436,"startTime":"0","endTime":"0","summary":"Lobe Sciences names David Kideckel CFO as Mirza Rahimani shifts to VP financeAppointed Dr. David Kideckel as CFO effective Sept. 1, 2026.Kideckel was a managing director leading life sciences at a pri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLbLMH27:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","LU2430703178.SGD","LU0949170426.SGD","LU1170363599.USD","LU0053666078.USD","LU0266013472.USD","03165","LU0545562505.USD","XLV","LU1718418525.SGD","IE00BSNM7G36.USD","LU2089984988.USD","RXL","IHE","AZN.UK","FHLC","LU1059921491.USD","LU0211327993.USD","SG9999001440.SGD","LU0210536198.USD","LU0964807845.USD","PJP","IXJ","BK4559","LU0234570918.USD","LU0310800965.SGD","LU0070217475.USD","LU0960981461.USD","BMED","GDOC","LU1228905037.USD","LU2756315318.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU0689472784.USD","TRUH","LU1301847155.USD","JDOC","BK4581","BK4534","MEDX","IE00BBT3K403.USD","VHT","IYH","LU0390134368.USD","FTXH","LU0859254822.USD","LU0203345920.USD","LU0889566641.SGD","LU2433249047.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662667970","title":"Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough","url":"https://stock-news.laohu8.com/highlight/detail?id=2662667970","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662667970?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:30","pubTimestamp":1787916600,"startTime":"0","endTime":"0","summary":"An mRNA cancer vaccine Moderna had been developing with Merck had hit its mark — the first success of a therapeutic cancer vaccine in late-stage testing after more than 100 years of failed attempts.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44N0PO:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","SG9999014567.USD","LU2112291526.USD","SG9999013999.USD","LU0320765489.SGD","LU1061106388.HKD","SG9999001440.SGD","BK4548","BK4534","LU2491049909.HKD","SG9999014575.USD","LU2125154778.USD","LU0965508806.USD","IE000M9KFDE8.USD","LU0130102774.USD","LU2125154935.USD","LU1923622614.USD","LU1934455277.USD","LU1934455863.HKD","LU2491050071.SGD","SG9999001176.SGD","LU0211331839.USD","LU2361044949.HKD","LU1162221912.USD","LU1066053197.SGD","LU2106854487.HKD","LU0859254822.USD","LU1699723380.USD","LU2089984988.USD","LU2360032135.SGD","LU1023059063.AUD","IE00B2B36J28.USD","LU1430594728.SGD","SGXZ57979304.SGD","LU0868494617.USD","LU0058720904.USD","LU1201861249.SGD","LU0689626769.HKD","BK4139","LU1983299246.USD","LU0203345920.USD","IE00B1BXHZ80.USD","IDNA","BK4568","LU0289739699.SGD","LU0320765646.SGD","FHLC","HRTS","LU1917777945.USD","LU1989771016.USD","MRK","LU1066051225.USD","LU0965509101.SGD","LU0130517989.USD","BK4559","BK4533","IE00BJJMRZ35.SGD","LU0868494708.USD","PAWZ","LU0648001328.SGD","LU0942090050.USD","LU1116320901.HKD","LU1571399168.USD","SG9999014542.SGD","LU1035773651.USD","LU0265550359.USD","IE00B4R5TH58.HKD","LU1989772923.USD","MRNX","LU2433249047.HKD","LU2468319806.SGD","SG9999002232.USD","LU1989772840.SGD","LGHT","LU1093756168.USD","XLV","LU2357627491.SGD","BK4588","LU1057294990.SGD","GDOC","LU0985320562.USD","TRUH","WDNA","IE00BBT3K403.USD","LU0208291251.USD","IYH","BK4501","LU0266013472.USD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","GNOM","LU0965509010.AUD","BK4551","LU0432979614.USD","LU0238689110.USD","LU2125909593.SGD","BMED","LU1941712348.USD","LU0965509283.SGD","LU0122379950.USD","LU2023250504.SGD","PPH","LU0106261372.USD","VHT","BK4007","LU1037948541.HKD","LU1929549753.HKD","LU2023250843.SGD","BK4550","IE0002141913.USD","LU0823416689.USD","BK4516","IE00BLSP4452.SGD","IHE","IXJ","LU1037948897.HKD","LU0861579265.USD","MRNY","LU0980610538.SGD","LU1941712264.USD","JDOC","SG9999001176.USD","LU2361044865.SGD","MRNA","RXL","LU0234572021.USD","LU2461242641.AUD","LU0124676726.USD","IE00BJT1NW94.SGD","LU1069347547.HKD","LU2491050154.USD","LU1934455194.USD","LU0477156953.USD","SG9999015341.SGD","LU1116320737.USD","SG9999015358.SGD","LU0070302665.USD","IE00BLSP4239.USD","IE0009355771.USD","LU2125909247.SGD","FTXH","LU0265550946.USD","IE00BN8TJ469.HKD","LU0098860793.USD","LU1066051498.USD","LU2324357040.USD","BK4585","LU1066051811.HKD","LU2361045086.USD","BK4532","LU1093756325.SGD","SG9999014559.SGD","LU0006306889.USD","LU1585245621.USD","SG9999002224.SGD","LU1291159041.SGD","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762030","title":"Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762030","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762030?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:17","pubTimestamp":1787883449,"startTime":"0","endTime":"0","summary":"Gilead breaks ground on Foster City biologics facility in $32 billion US investment pushGilead broke ground on its Chess biologics facility at its Foster City, California headquarters as part of a pla","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL98vB5b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU1066053197.SGD","BMED","LU1934455863.HKD","BK4588","LU1037948541.HKD","IE0002270589.USD","LU0109394709.USD","LU0289739699.SGD","LU1430594728.SGD","LU1057294990.SGD","BK4568","LU2324357040.USD","LU0861579265.USD","LU2357627491.SGD","LU0965509010.AUD","LU1066051498.USD","LU1571399168.USD","LU2112291526.USD","BBH","LU1934455194.USD","BK4532","IBB","LU0234570918.USD","BK4578","IE00BSNM7G36.USD","LU0859254822.USD","LU0320765992.SGD","LU0889565916.HKD","TBXU","SG9999015952.SGD","LU1674673691.USD","BK4583","LU0823416689.USD","IE00BKVL7J92.USD","LU2087621335.USD","LU1674673428.USD","IBBQ","LU1061106388.HKD","LU0965508806.USD","MEDI","GILD","LU0965509283.SGD","LU1037948897.HKD","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0058720904.USD","BIB","TMED","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031648","title":"SomnoMed Tightens Insider Trading Rules With New Securities Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031648","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662031648?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:19","pubTimestamp":1787872792,"startTime":"0","endTime":"0","summary":"The latest update is out from Somnomed Limited ( ($AU:SOM) ). SomnoMed Limited operates in the medical devices sector, focusing on oral appliance t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/somnomed-tightens-insider-trading-rules-with-new-securities-policy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/somnomed-tightens-insider-trading-rules-with-new-securities-policy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEHS","MDTX","HART","HRTS","CURE","XT","IBRN","RSPH","FHLC","BMED","LNGR","MEDI","PINK","AGNG","GDOC","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662394370","title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662394370","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662394370?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:45","pubTimestamp":1787870729,"startTime":"0","endTime":"0","summary":"Gilead Sciences director Anthony Welters disposes of USD 2.64 million in common sharesGilead director Anthony Welters exercised stock options for 18,000 shares on Aug. 26, 2026 at prices of USD 60.67 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL29Bbzm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0965509101.SGD","IE00BSNM7G36.USD","LU2112291526.USD","LU1057294990.SGD","BK4139","LU0861579265.USD","LU1674673428.USD","LU0965508806.USD","BMED","LU1037948897.HKD","LU1066051498.USD","LU0289739699.SGD","LU1571399168.USD","LU1585245621.USD","LU0320765992.SGD","TMED","GILD","IBBQ","LU0058720904.USD","LU1839511570.USD","TBXU","BK4568","MEDI","BK4585","BK4532","LU0965509010.AUD","LU1430594728.SGD","LU0859254822.USD","LU2087621335.USD","BK4566","LU1934455863.HKD","BIB","IE00B3T34201.USD","IE00B19Z3581.USD","BK4578","IE00B7SZLL34.SGD","BBH","LU0889565916.HKD","LU2324357040.USD","LU1023059063.AUD","BK4583","IE00B19Z3B42.SGD","LU1061106388.HKD","BK4588","LU0122379950.USD","IE0002270589.USD","SG9999015986.USD","LU0823416689.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036059","title":"Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036059","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036059?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:55","pubTimestamp":1787867719,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced that the FDA approved Bixlenvo – bictegravir 75 mg/lenacapavir 50 mg -, the smallest once-daily single tablet regi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1061106388.HKD","IBBQ","LU1585245621.USD","IBB","LU1023059063.AUD","LU1934455194.USD","LU2324357040.USD","BIB","LU2357627491.SGD","MEDI","IE00B19Z3581.USD","LU1674673428.USD","GILD","LU1674673691.USD","SG9999015986.USD","LU0965509101.SGD","LU1066053197.SGD","IE00BSNM7G36.USD","LU0109394709.USD","LU0861579265.USD","LU2087621335.USD","LU0058720904.USD","LU1057294990.SGD","BK4588","LU0122379950.USD","LU1066051498.USD","LABU","LU1839511570.USD","LU0889565916.HKD","BK4532","TBXU","IE00B19Z3B42.SGD","LU1571399168.USD","LU0965509283.SGD","LU1934455863.HKD","SG9999015952.SGD","BK4583","TMED","SG9999015945.SGD","BMED","IE00BZ1G4Q59.USD","BK4585","BBH","BK4568","LU0859254822.USD","LU1037948897.HKD","LU0823416689.USD","BK4566","BK4139","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036301","title":"US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036301","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036301?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867441,"startTime":"0","endTime":"0","summary":"US FDA approves Gilead's once-daily combination pill for HIV treatmentAug 27 -The U.S. Food and Drug Administration has approved Gilead Sciences'GILD.Oonce daily oral combination pill for treatment of adults whose HIV has already been reduced to very low levels, the company said on Thursday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O24M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","IBBQ","LU1585245621.USD","IBB","LU1023059063.AUD","IE00B7SZLL34.SGD","LU2324357040.USD","BIB","IE00B3T34201.USD","LU2357627491.SGD","IE00B19Z3581.USD","MEDI","LU0882574055.USD","LU1674673428.USD","BK4578","GILD","LU0965509101.SGD","LU0861579265.USD","LU2468319806.SGD","LU0058720904.USD","LU1057294990.SGD","BK4588","IE0002270589.USD","LU0122379950.USD","LU1066051498.USD","LU1934455277.USD","LU1037948541.HKD","LU1839511570.USD","LU0965509010.AUD","LU0889565916.HKD","TBXU","LU0114720955.EUR","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1934455863.HKD","SG9999015952.SGD","BK4583","LU1778281490.HKD","LU0965508806.USD","SG9999015945.SGD","BMED","LU0289739699.SGD","TMED","IE00BZ1G4Q59.USD","BK4585","BBH","LU1037948897.HKD","BK4566","BK4139","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036807","title":"U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036807?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:47","pubTimestamp":1787867220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA7M9KZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1430594728.SGD","BK4566","LU2089984988.USD","LU1934455863.HKD","IE00B19Z3B42.SGD","LU1057294990.SGD","IBB","LU0861579265.USD","BK4550","GILD","LU1778281490.HKD","BK4568","LU0289739699.SGD","LU1037948897.HKD","TBXU","BBH","BK4583","LU1066053197.SGD","BK4578","BMED","IE00BKVL7J92.USD","TMED","BK4585","IE00BZ1G4Q59.USD","LU0823416689.USD","LU2112291526.USD","LU2468319806.SGD","LU0320765992.SGD","LU0965509010.AUD","SG9999015978.USD","BIB","SG9999015945.SGD","LU0889565916.HKD","BK4588","LU1571399168.USD","LU0882574055.USD","IE00B3T34201.USD","LU1934455194.USD","LU1066051498.USD","LU0234570918.USD","LU0109394709.USD","IE00B7SZLL34.SGD","LU1934455277.USD","LU1839511570.USD","LU1061106388.HKD","BK4532","MEDI","IBBQ","LU0965509283.SGD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703343","title":"Medtronic PLC Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703343","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703343?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:39","pubTimestamp":1787863140,"startTime":"0","endTime":"0","summary":"DJ Medtronic PLC Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Medtronic PLC  shed 2.23% to $89.97 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.72% to 7,730.99 and the Dow Jones Industrial Average  rising 0.20% to 53,569.44.Medtronic PLC closed 15.39% below its 52-week high of $106.33, which the company reached on November 26th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 1.57% to $265.77, Danaher Corp.  rose 0.15% to $215.68, and Abbott Laboratories  fell 2.20% to $111.59.Trading volume  remained 190,833 below its 50-day average volume of 7.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930813.SGD","DHR","SG9999001440.SGD","VHT","IE00BSNM7G36.USD","SGXZ41872573.SGD","LU0098860793.USD","BMED","MDT","LU2756315664.SGD","IYH","LU1057294990.SGD","LU0114720955.EUR","IE0002141913.USD","LU2324357040.USD","LU0053666078.USD","SG9999002232.USD","LU0689626769.HKD","IE00BJT1NW94.SGD","ABT","LU1066051811.HKD","IHI","LU2896262040.SGD","RXL","LU0314106906.USD","LU0985320562.USD","BK4007","TMED","LU2125909247.SGD","XLV","LU0689472784.USD","LU1721429402.USD","LU1430594728.SGD","LU2471134952.CNY","TRUH","LU1721429741.USD","MEDX","LU1221951129.SGD","IE00BQXX3C00.GBP","FMED","FTXH","JNJ","FHLC","PJP","IE0004445239.USD","GDOC","IHE","BK4534","JDOC","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033626","title":"Moderna Inc. Stock Slips 4.6%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033626?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:34","pubTimestamp":1787862840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 4.6% to $142.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.6% to 26,541.35 and the Dow Jones Industrial Average rising 0.2% to 53,569.44.This was the stock's second consecutive day of losses.Moderna Inc. closed 19.2% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.6% to $265.77, Pfizer Inc. fell 1.0% to $28.02, and Gilead Sciences Inc. rose 0.52% to $148.86.Trading volume totaled 24.9 million, compared to the 50-day average of 16.4 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","LU1934455277.USD","IE00B7SZLL34.SGD","LU0109394709.USD","BK4583","TMED","LU0861579265.USD","LU0114720955.EUR","SG9999015986.USD","BK4534","LU2468319806.SGD","LU1674673691.USD","MRNX","LGHT","LU0965509010.AUD","LU1571399168.USD","WDNA","MEDI","SG9999015952.SGD","LU2357627491.SGD","LU2324357040.USD","LU1934455194.USD","MRNA","TBXU","LU1061106388.HKD","BK4533","BK4588","IE00BKVL7J92.USD","LU0965508806.USD","MRNY","GNOM","LU0058720904.USD","BK4550","LU1037948541.HKD","IBBQ","LU1674673428.USD","LU1066053197.SGD","IE00B19Z3581.USD","SG9999015945.SGD","GILD","BK4551","BK4568","LU0320765992.SGD","LU0889565916.HKD","BIB","IDNA","IBB","BBH","BK4139","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662389720","title":"Biogen CEO Viehbacher to Speak at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662389720","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662389720?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:10","pubTimestamp":1787861436,"startTime":"0","endTime":"0","summary":"Biogen CEO Viehbacher to speak at Morgan Stanley Global Healthcare ConferenceBiogen CEO Christopher A. Viehbacher to join a fireside chat at Morgan Stanley’s 24th Annual Global Healthcare Conference on Sept. 14, 2026.Webcast scheduled for 9:15 a.m. ET.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biogen Inc. published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8TV47S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB","PBE","IE00B19Z9P08.USD","BK4533","BK4532","IE00B19Z9Z06.USD","LU0889565916.HKD","BK4139","IE00B894F039.SGD","LU0109394709.USD","BK4588","LU0320765992.SGD","BMED","BK4585","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084970","title":"ABL Diagnostics Calls Shareholder Vote on Move to Euronext Growth and Name Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084970","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084970?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:37","pubTimestamp":1787848643,"startTime":"0","endTime":"0","summary":"An update from ABL Diagnostics SA ( ($FR:ABLD) ) is now available. ABL Diagnostics SA, a publicly listed French molecular diagnostics group, provid...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abl-diagnostics-calls-shareholder-vote-on-move-to-euronext-growth-and-name-change?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abl-diagnostics-calls-shareholder-vote-on-move-to-euronext-growth-and-name-change?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","GNMX","HELX","ABLD","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195720547","title":"IMMUNEONCO-B Advances Phase II Trial for First-Line Advanced Liver Cancer Therapy With Initial Patient Dosing Completed","url":"https://stock-news.laohu8.com/highlight/detail?id=1195720547","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195720547?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:24","pubTimestamp":1787837055,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced that the Phase II clinical trial evaluating IMM2510 (Peravrafusp alfa) in combination with IMM27M (Tazebsumab) as a first-line treatment for patients with advanced...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","COAL","IBBJ","BMED","HCC","01541","BK1161","MDTX","BK4006","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191071495","title":"CSPC Pharma's High-Activity Amylin Receptor Agonist Gets Green Light for Clinical Trials in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1191071495","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191071495?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:30","pubTimestamp":1787826628,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its developed SYH2092 injection has received approval from China's National Medical Products Administration to proceed with clinical trials within the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0067412154.USD","LU0326950275.SGD","IBBQ","IE0008368742.USD","LU2039709279.SGD","LU1226288170.HKD","SG9999004220.SGD","LU0140636845.USD","IE00B5MMRT66.SGD","01093","BMED","IE00BZ08YS42.EUR","KURE","LU1328277881.USD","LU0072913022.USD","LU0314109678.HKD","LU1152091754.HKD","PSYK","LU1008478684.HKD","LU1226287529.USD","LU1807302812.USD","BK1191","BK1515","LU0880133367.SGD","LU1226287792.SGD","LU1951186391.HKD","IE00B543WZ88.USD","IE00B031HY20.USD","LU1813983027.USD","LU1152091168.USD","BK1521","LU1960683339.HKD","LU1226287875.USD","HK0000165453.HKD","LU1226288253.USD","LU0501845795.SGD","IE0008369823.USD","IE00BZ08YT58.USD","LU1993786604.SGD","MDTX","IE00BZ08YR35.GBP","IBBJ","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774764","title":"China Approves J&J's Oral Psoriasis Pill, Says Drugmaker","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774764","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774764?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:47","pubTimestamp":1787820442,"startTime":"0","endTime":"0","summary":"China approves J&J's oral psoriasis pill, says drugmakerSHANGHAI, Aug 27 (Reuters)-Johnson & JohnsonJNJ.Nsaid on Thursday that its oral drug icotrokinra was approved in China for moderate-to-severe plaque psoriasis.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O0QI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","LU0426412945.USD","GDOC","LU1061106388.HKD","LU2756315318.SGD","IE00BJJMRZ35.SGD","IHE","IE00BBT3K403.USD","LU2236285917.USD","XLV","LU1032955483.USD","JNJ","LU0689472784.USD","LU1228905037.USD","FTXH","LU0640476718.USD","LU1221951046.USD","TRUH","IE00BLSP4239.USD","LU0795875169.SGD","LU1059921491.USD","LU1935042991.SGD","LU0820561909.HKD","LU2129689605.HKD","LU1551013342.USD","BMED","LU0466842654.USD","IE00BKVL7J92.USD","LU1732799900.SGD","BK4588","BK4534","IE00B19Z3B42.SGD","LU0689626769.HKD","VHT","LU0162691827.USD","LU1057294990.SGD","MEDX","LU0122379950.USD","JDOC","LU0795875086.SGD","IXJ","LU1043141396.HKD","IE00BGHQF631.EUR","PJP","RXL","LU1244550577.SGD","IYH","LU1162221912.USD","FHLC","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}